Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ziyi Fu

Showing results (121-130 of 125) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 125 results.
Nano Letters|March 5, 2025
Room-Temperature Exciton Polaritons in Monolayer WS<sub>2</sub> Enabled by Plasmonic Bound States in the ContinuumCai Luo, Wei Li, Jianmei Li, et al.
Science Advances|January 6, 2023
Proteolytic regulation of CD73 by TRIM21 orchestrates tumor immunogenicityZiyi Fu, Siqi Chen, Yueming Zhu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 16, 2023
N4-Acetylcytidine Drives Glycolysis Addiction in Gastric Cancer via NAT10/SEPT9/HIF-1α Positive Feedback LoopQingbin Yang, Xuetao Lei, Jiayong He, et al.
Cancer Medicine|November 7, 2023
Efficacy and safety of the proposed bevacizumab biosimilar BAT1706 compared with reference bevacizumab in patients with advanced nonsquamous non-small cell lung cancer: A randomized, double-blind, phase III studyLikun Chen, Jose David Gomez Rangel, Timucin Cil, et al.
BMC Cancer|April 1, 2020
Lapatinib in combination with capecitabine versus continued use of trastuzumab in breast cancer patients with trastuzumab-resistance: a retrospective study of a Chinese populationFan Yang, Xiang Huang, Chunxiao Sun, et al.
Pageof 13

Showing results (121-130 of 125) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 125 results.
Nano Letters|March 5, 2025
Room-Temperature Exciton Polaritons in Monolayer WS<sub>2</sub> Enabled by Plasmonic Bound States in the ContinuumCai Luo, Wei Li, Jianmei Li, et al.
Science Advances|January 6, 2023
Proteolytic regulation of CD73 by TRIM21 orchestrates tumor immunogenicityZiyi Fu, Siqi Chen, Yueming Zhu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 16, 2023
N4-Acetylcytidine Drives Glycolysis Addiction in Gastric Cancer via NAT10/SEPT9/HIF-1α Positive Feedback LoopQingbin Yang, Xuetao Lei, Jiayong He, et al.
Cancer Medicine|November 7, 2023
Efficacy and safety of the proposed bevacizumab biosimilar BAT1706 compared with reference bevacizumab in patients with advanced nonsquamous non-small cell lung cancer: A randomized, double-blind, phase III studyLikun Chen, Jose David Gomez Rangel, Timucin Cil, et al.
BMC Cancer|April 1, 2020
Lapatinib in combination with capecitabine versus continued use of trastuzumab in breast cancer patients with trastuzumab-resistance: a retrospective study of a Chinese populationFan Yang, Xiang Huang, Chunxiao Sun, et al.
Pageof 13